Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Community-Based Interventions for Infant Health in Nepal

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2008 by Institute of Child Health.
Recruitment status was:  Recruiting
Information provided by:
Institute of Child Health Identifier:
First received: December 22, 2006
Last updated: April 7, 2008
Last verified: April 2008
An Evaluation of the Cost-Effectiveness of Community-Based Participatory Interventions for Pregnant Women in Nepal to Reduce Fetal & Infant Mortality and to Improve Fetal Growth & Cognitive Development in Infancy

Condition Intervention Phase
Child Mortality
Drug: Methotrexate
Phase 1

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: An Evaluation of the Cost-Effectiveness of Community-Based Participatory Interventions for Pregnant Women in Nepal to Reduce Fetal and Infant Mortality, and to Improve Fetal Growth and Cognitive Development in Infancy.

Resource links provided by NLM:

Further study details as provided by Institute of Child Health:

Primary Outcome Measures:
  • neonatal mortality rates [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 192000
Study Start Date: March 2005
Estimated Study Completion Date: December 2008
Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Methotrexate

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
48 village development committee areas

Inclusion Criteria:

  • mothers, community health volunteers

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00656591

United Kingdom
International Child Health, ICH
London, United Kingdom, WC1N 1EH
Sponsors and Collaborators
Institute of Child Health
Principal Investigator: Anthony Costello, Dr Institute of Child Health
  More Information

Responsible Party: R&D Office, Institute of Child Health Identifier: NCT00656591     History of Changes
Other Study ID Numbers: 04PC01 
Study First Received: December 22, 2006
Last Updated: April 7, 2008
Health Authority: United Kingdom: National Health Service
United Kingdom: Research Ethics Committee

Keywords provided by Institute of Child Health:
Child mortality, Nepal, Community, care practices

Additional relevant MeSH terms:
Abortifacient Agents, Nonsteroidal
Abortifacient Agents
Reproductive Control Agents
Physiological Effects of Drugs
Antimetabolites, Antineoplastic
Molecular Mechanisms of Pharmacological Action
Antineoplastic Agents
Dermatologic Agents
Enzyme Inhibitors
Folic Acid Antagonists
Immunosuppressive Agents
Immunologic Factors
Antirheumatic Agents
Nucleic Acid Synthesis Inhibitors processed this record on December 09, 2016